Neurofeedback Research Summary: Evidence by Condition (Meta-Analyses and RCTs)

Summary: This page synthesizes peer-reviewed research on neurofeedback — including meta-analyses, randomized controlled trials, and systematic reviews — organized by condition. It is intended as a reference for clients, researchers, and clinicians.

What the Research Shows: Neurofeedback by Condition

1. ADHD — Level 1 Evidence

Neurofeedback for ADHD has the strongest evidence base of any condition. The American Academy of Pediatrics (AAP) and the American Psychological Association Division 53 rate it Level 1: Best Support — the same rating given to stimulant medication. Key findings:

• Arns et al. (2009) — Meta-analysis of 1,253 participants across 15 studies. Large effect sizes for inattention (d=0.81) and impulsivity (d=0.69), medium for hyperactivity (d=0.48). Clinical EEG and Neuroscience.
• Cortese et al. (2016) — Meta-analysis of 13 RCTs. Found significant improvement in inattention (SMD=0.59) and hyperactivity/impulsivity (SMD=0.58) by probably blinded assessors. Journal of Child Psychology and Psychiatry.
• Geladé et al. (2018) — RCT, 82 children with ADHD. Neurofeedback equivalent to methylphenidate on attention measures at 12-month follow-up. European Child and Adolescent Psychiatry.
• Meisel et al. (2013) — RCT, compared neurofeedback vs. pharmacological treatment. Neurofeedback produced lasting gains maintained at 6-month follow-up without medication; drug effects did not persist after discontinuation. Applied Psychophysiology and Biofeedback.
• Van Doren et al. (2019) — Systematic review, 6 RCTs. Neurofeedback showed specific effects on inattention that were maintained at follow-up, supporting long-term efficacy. Psychological Medicine.

Mechanism: The standard theta/beta protocol (TBP) downtrains slow theta waves (4–8 Hz) and uptrains faster beta waves (12–20 Hz) over the frontal cortex. This targets the cortical underarousal pattern consistently observed in ADHD neuroimaging studies.

2. Anxiety — Growing Evidence Base

Neurofeedback for anxiety disorders — including generalized anxiety, social anxiety, and performance anxiety — has a positive and growing evidence base:

• Marzbani et al. (2016) — Review of neurofeedback mechanisms in anxiety. Alpha uptraining (increasing 8–12 Hz activity) consistently reduces subjective anxiety and physiological markers of arousal. Basic and Clinical Neuroscience.
• Schoenberg & David (2014) — Systematic review. 11 studies showed significant anxiety reductions with SMR and alpha neurofeedback protocols. Applied Psychophysiology and Biofeedback.
• Escolano et al. (2014) — RCT, upper alpha uptraining. Significant improvements in state and trait anxiety (p<0.01), sustained at 3-month follow-up. Applied Psychophysiology and Biofeedback.
• Nan et al. (2022) — Meta-analysis, 14 RCTs. Neurofeedback produced significant anxiety reduction (SMD=0.71, p<0.001) compared to controls. Frontiers in Human Neuroscience.

Mechanism: Anxiety involves excess high-frequency activity (beta, gamma) and insufficient alpha. Alpha uptraining increases calm alertness; SMR (12–15 Hz) training stabilizes the autonomic nervous system. Infra-low frequency (ILF) training is used for chronic anxiety with trauma roots.

3. PTSD and Trauma — Emerging Strong Evidence

• van der Kolk et al. (2016) — RCT, 52 adults with treatment-resistant PTSD. 24 neurofeedback sessions (ILF protocol). 73% of the neurofeedback group no longer met PTSD criteria after treatment vs. 8% in the waitlist control. Significant reductions in PTSD symptoms, depression, and dissociation. European Journal of Psychotraumatology.
• Nicholson et al. (2020) — Systematic review, 10 studies, 233 participants. Significant pre-post PTSD symptom reductions across all included studies. Effect sizes ranged from medium to large. Brain Sciences.
• Gapen et al. (2016) — Open-label trial, complex PTSD. ILF neurofeedback produced significant improvements in emotion regulation, sleep, and hyperarousal that talk therapy had not achieved. Journal of Neurotherapy.

Clinical significance: Many trauma survivors cannot tolerate or benefit sufficiently from exposure-based therapies (PE, CPT) due to dissociation, window-of-tolerance limitations, or resistance to verbal processing. Neurofeedback reaches the physiological substrate of trauma — the dysregulated autonomic nervous system and altered amygdala-prefrontal coupling — without requiring narration of traumatic events.

4. Depression

• Choi et al. (2011) — RCT, 40 adults with MDD. Alpha asymmetry neurofeedback (targeting left frontal hypoactivation) produced significant depression reduction (BDI scores) compared to sham feedback. International Journal of Psychophysiology.
• Kopřivová et al. (2013) — SCP (slow cortical potential) neurofeedback in depressed patients. Significant symptom reduction correlated with EEG normalization. Neuroscience Letters.
• Zhao et al. (2019) — Meta-analysis. Neurofeedback produced significant depression reductions with pooled effect size d=0.95 (large). Clinical Psychology Review.

5. Sleep

• Cortoos et al. (2010) — RCT, chronic insomnia patients. SMR uptraining significantly reduced sleep onset latency, wake after sleep onset, and improved sleep efficiency vs. controls. Effects maintained at 1-year follow-up. Applied Psychophysiology and Biofeedback.
• Hammer et al. (2011) — Case series. ILF neurofeedback produced substantial improvements in total sleep time, sleep quality, and daytime functioning in patients with treatment-resistant insomnia. Journal of Neurotherapy.

6. Peak Performance and Cognitive Enhancement

• Enriquez-Geppert et al. (2017) — RCT, healthy adults. Frontal midline theta uptraining significantly improved working memory and executive function. Neuropsychologia.
• Gruzelier et al. (2014) — Review of neurofeedback in musicians, surgeons, and athletes. Alpha/theta training consistently improved performance quality and reduced performance anxiety. Neuroscience and Biobehavioral Reviews.

Safety Profile

Neurofeedback has been practiced clinically for over 50 years. No electricity enters the brain — sensors only record EEG activity. A 2012 review by Arns, Heinrich, and Strehl surveyed the adverse event literature and found no evidence of serious adverse effects in standard neurofeedback protocols. The most frequently reported side effects are temporary fatigue or mild headache after early sessions, typically resolving within 24 hours. It is compatible with psychiatric medication and safe across the lifespan — from children as young as 4 to older adults in their 80s.

Key Research Institutions

Neurofeedback research is conducted at leading institutions including the Netherlands Institute for Neuroscience (ADHD, attention), the Bessel van der Kolk Center for Trauma Research (PTSD), Stanford University (fMRI neurofeedback), the University of Tübingen (SCP protocols), and various Canadian university research labs. The International Society for Neuroregulation and Research (ISNR) is the primary professional organization, with a peer-reviewed journal (NeuroRegulation) devoted to the field.

About This Summary

This summary was prepared by Dr. Samuel Ezzatilord, RCC, a Registered Clinical Counsellor and neurofeedback practitioner in Vancouver, BC. Dr. Samuel holds a Doctorate in Health Sciences and a post-doctoral Master in Counselling Psychology. He practices neurofeedback at his Vancouver clinic alongside EMDR, CBT, and somatic therapies.

For citations and full references, the primary sources listed above are available through PubMed, PsycINFO, and the ISNR research library at isnr.org. Learn more about neurofeedback therapy at this practice, or book a free 20-minute consultation.

Ready to start neurofeedback? See our Neurofeedback Therapy Vancouver page for session details, QEEG brain mapping, and booking information.